Sporadic early-onset colon cancer expresses unique molecular features

Journal of Surgical Research

Volumn 204, Issue 1, 2016, Pages 251-260

  Jandova, Jana ^a,b   Xu, Wenjie ^c   Nfonsam, Valentine ^a,b  

^a UNIVERSITY OF ARIZONA   (United States)

^b UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

^c NANOSTRING TECHNOLOGIES   (United States)

Author keywords

Gene expression profiling; Pathway analysis; Sporadic early onset colon cancer

Indexed keywords

CARTILAGE OLIGOMERIC MATRIX PROTEIN; CELL CYCLE PROTEIN 6; CHECKPOINT KINASE 2; CILIARY NEUROTROPHIC FACTOR RECEPTOR ALPHA; DNA; FANCONI ANEMIA GROUP A PROTEIN; FIBROBLAST GROWTH FACTOR 2; FIBROBLAST GROWTH FACTOR 21; FIBROBLAST GROWTH FACTOR RECEPTOR 1; HIGH MOBILITY GROUP A1A PROTEIN; HISTONE DEACETYLASE 5; MATRILYSIN; MINICHROMOSOME MAINTENANCE PROTEIN 7; MISMATCH REPAIR PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; TRANSCRIPTION FACTOR 7 LIKE 1; TRANSCRIPTION FACTOR SOX9; TRANSFORMING GROWTH FACTOR BETA; WNT PROTEIN; TUMOR MARKER;

ADULT; AGED; ARTICLE; CACNB2 GENE; CD19 GENE; CELL CYCLE; CHAD GENE; COL11A1 GENE; COL1A1 GENE; COLON CANCER; COMP GENE; CONTROLLED STUDY; DNA REPAIR; DOWN REGULATION; EARLY CANCER; ETV4 GENE; FEMALE; FIGF GENE; FN1 GENE; GENE; GENE CONTROL; GENE EXPRESSION REGULATION; GZMB GENE; HSP2 GENE; HUMAN; HUMAN TISSUE; INHBA GENE; ITGA2 GENE; ITGA7 GENE; KAT2B GENE; KIT GENE; LATE ONSET DISORDER; LIF GENE; MALE; MAPK8IP2 GENE; MAPT GENE; MOLECULAR DYNAMICS; PRIORITY JOURNAL; PRKCB GENE; PROTEIN EXPRESSION; RASGRP2 GENE; RXRG GENE; SIGNAL TRANSDUCTION; TTK GENE; UPREGULATION; ADENOCARCINOMA; CASE CONTROL STUDY; COLON TUMOR; GENE EXPRESSION PROFILING; GENETICS; METABOLISM; MICROSATELLITE INSTABILITY; MIDDLE AGED; ONSET AGE; PATHOLOGY; VERY ELDERLY;

ADENOCARCINOMA; ADULT; AGE OF ONSET; AGED; AGED, 80 AND OVER; BIOMARKERS, TUMOR; CASE-CONTROL STUDIES; COLONIC NEOPLASMS; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MALE; MICROSATELLITE INSTABILITY; MIDDLE AGED;

EID: 84979583821     PISSN: 00224804     EISSN: 10958673     Source Type: Journal    
DOI: 10.1016/j.jss.2016.04.068     Document Type: Article

References (37)

1. 1 Ferlay, J., Shin, H.R., Bray, F., Forman, D., Mathers, C., Parkin, D.M., Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 127 (2010), 2893–2917.
2. 2 Siegel, R.L., Miller, K.D., Jemal, A., Cancer statistics, 2015. CA Cancer J Clin 65 (2015), 5–29.
3. 3 Siegel, R., DeSantis, C., Jemal, A., Colorectal cancer statistics, 2014. CA Cancer J Clin 64 (2014), 104–117.
4. 4 Kirzin, S., Marisa, L., Guimbaud, R., et al. Sporadic early-onset colorectal cancer is a specific sub-type of cancer: a morphological, molecular and genetics study. PLoS One, 9(8), 2014.
5. 5 Davis, D.M., Marcet, J.E., Frattini, J.C., Prather, A.D., Mateka, J.J.L., Nfonsam, V.N., Is it time to lower the recommended screening age for colorectal cancer?. J Am Coll Surg 213 (2011), 352–361.
6. 6 Nfonsam, V.N., Pandit, V., DiGiovanni, R.M., et al. Increased incidence of early onset colorectal cancer in Arizona: a comprehensive 15-year analysis of the Arizona Cancer Registry. J Gastrointest Dig Syst, 5, 2015, 5.
7. 7 Edwards, B.K., Ward, E., Kohler, B.A., et al. Annual report to the nation on the status of cancer, 1975-2006, featuring colorectal cancer trends and impact of interventions (risk factors, screening, and treatment) to reduce future rates. Cancer 116 (2010), 544–573.
8. 8 Ahnen, D.J., Wade, S.W., Jones, W.F., et al. The increasing incidence of young-onset colorectal cancer: a call to action. Mayo Clin Proc 89 (2014), 216–224.
9. 9 Zahir, M.N., Azhar, E.M., Rafiq, S., Ghias, K., Shabbir-Moosajee, M., Clinical features and outcome of sporadic colorectal carcinoma in young patients: a cross-sectional analysis from a developing country. ISRN Oncol, 2014, 2014, 461570.
10. 10 Myers, E.A., Feingold, D.L., Forde, K.A., Arnell, T., Jang, J.H., Whelan, R.L., Colorectal cancer in patients under 50 years of age: a retrospective analysis of two institutions' experience. World J Gastroenterol 19 (2013), 5651–5657.
11. 11 Bacani, J., Zwingerman, R., Di Nicola, N., et al. Tumor microsatellite instability in early onset gastric cancer. J Mol Diagn 7 (2005), 465–477.
12. 12 Giraldez, M.D., Balaguer, F., Bujanda, L., et al. MSH6 and MUTYH Deficiency is a frequent event in early-onset colorectal Cancer. Clin Cancer Res 16 (2010), 5402–5413.
13. 13 Chang, D.T., Pai, R.K., Rybicki, L.A., et al. Clinicopathologic and molecular features of sporadic early-onset colorectal adenocarcinoma: an adenocarcinoma with frequent signet ring cell differentiation, rectal and sigmoid involvement, and adverse morphologic features. Mod Pathol 25 (2012), 1128–1139.
14. 14 Antelo, M., Balaguer, F., Shia, J.R., et al. A high degree of LINE-1 Hypomethylation is a unique feature of early-onset colorectal Cancer. PLoS One, 7(9), 2012, e45357.
15. 15 Budinska, E., Popovici, V., Tejpar, S., et al. Gene expression patterns unveil a new level of molecular heterogeneity in colorectal cancer. J Pathol 231 (2013), 63–76.
16. 16 Jass, J.R., Molecular heterogeneity of colorectal cancer: implications for cancer control. Surg Oncol 16 (2007), S7–S9.
17. 17 Fearon, E.R., Molecular genetics of colorectal Cancer. Annu Rev Pathol 6 (2011), 479–507.
18. 18 Hur, K., Cejas, P., Feliu, J., et al. Hypomethylation of long interspersed nuclear element-1 (LINE-1) leads to activation of proto-oncogenes in human colorectal cancer metastasis. Gut 63 (2014), 635–646.
19. 19 Buhard, O., Cattaneo, F., Wong, Y.F., et al. Multipopulation analysis of polymorphisms in five mononucleotide repeats used to determine the microsatellite instability status of human tumors. J Clin Oncol 24 (2006), 241–251.
20. 20 Xicola, R.M., Llor, X., Pons, E., et al. Performance of different microsatellite marker panels for detection of mismatch repair-deficient colorectal tumors. J Natl Cancer Inst 99 (2007), 244–252.
21. 21 Geiss, G.K., Bumgarner, R.E., Birditt, B., et al. Direct multiplexed measurement of gene expression with color-coded probe pairs. Nat Biotechnol 26 (2008), 317–325.
22. 22 Hanahan, D., Weinberg, R.A., The hallmarks of cancer. Cell 100 (2000), 57–70.
23. 23 Hanahan, D., Weinberg, R.A., Hallmarks of cancer: the next generation. Cell 144 (2011), 646–674.
24. 24 Vogelstein, B., Kinzler, K.W., Cancer genes and the pathways they control. Nat Med 10 (2004), 789–799.
25. 25 Vogelstein, B., Papadopoulos, N., Velculescu, V.E., Zhou, S.B., Diaz, L.A., Kinzler, K.W., Cancer genome Landscapes. Science 339 (2013), 1546–1558.
26. 26 Tunca, B., Tezcan, G., Cecener, G., et al. Overexpression of CK20, MAP3K8 and EIF5A correlates with poor prognosis in early-onset colorectal cancer patients. J Cancer Res Clin 139 (2013), 691–702.
27. 27 Luo, T., Wu, S., Shen, X., Li, L., Network cluster analysis of protein-protein interaction network identified biomarker for early onset colorectal cancer. Mol Biol Rep 40 (2013), 6561–6568.
28. 28 Chen, J., Xi, J., Tian, Y., Bova, G.S., Zhang, H., Identification, prioritization, and evaluation of glycoproteins for aggressive prostate cancer using quantitative glycoproteomics and antibody-based assays on tissue specimens. Proteomics 13 (2013), 2268–2277.
29. 29 Brabletz, T., Jung, A., Dag, S., Hlubek, F., Kirchner, T., Beta-catenin regulates the expression of the matrix metalloproteinase-7 in human colorectal cancer. Am J Pathol 155 (1999), 1033–1038.
30. 30 Maurel, J., Nadal, C., Garcia-Albeniz, X., et al. Serum matrix metalloproteinase 7 levels identifies poor prognosis advanced colorectal cancer patients. Int J Cancer 121 (2007), 1066–1071.
31. 31 Tennstedt, P., Fresow, R., Simon, R., et al. RAD51 overexpression is a negative prognostic marker for colorectal adenocarcinoma. Int J Cancer 132 (2013), 2118–2126.
32. 32 Moss, A.C., Lawlor, G., Murray, D., et al. ETV4 and Myeov knockdown impairs colon cancer cell line proliferation and invasion. Biochem Biophys Res Commun 345 (2006), 216–221.
33. 33 Matheu, A., Collado, M., Wise, C., et al. Oncogenicity of the developmental transcription factor Sox9. Cancer Res 72 (2012), 1301–1315.
34. 34 Lu, B., Fang, Y., Xu, J., et al. Analysis of SOX9 expression in colorectal cancer. Am J Clin Pathol 130 (2008), 897–904.
35. 35 Vara, J.A.F., Casado, E., de Castro, J., Cejas, P., Belda-Iniesta, C., Gonzalez-Baron, M., PI3K/Akt signalling pathway and cancer. Cancer Treat Rev 30 (2004), 193–204.
36. 36 Anastas, J.N., Moon, R.T., WNT signalling pathways as therapeutic targets in cancer. Nat Rev Cancer 13 (2013), 11–26.
37. 37 Polakis, P., Wnt signaling in cancer. Cold Spring Harb Perspect Biol 4:5 (2012), 1–13.